Tethered Dimers as NAD Synthetase Inhibitors with Antibacterial Activity
- 17 June 2003
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (15) , 3371-3381
- https://doi.org/10.1021/jm030003x
Abstract
The solution-phase parallel synthesis of tethered dimers was employed to identify lead inhibitors of bacterial NAD synthetase. Active dimers contained two aromatic end groups joined by a polymethylene linker, with one end group containing a permanent positive charge. Effective inhibitors of NAD synthetase also inhibited the growth of Gram-positive (but not Gram-negative) bacteria, including antibiotic-resistant strains. The desmethyl precursors of active inhibitors lacked a permanent positive charge and were inactive as either enzyme inhibitors or antibacterial agents. Similarly, a close structural analogue of the most active inhibitors contained two additional ether oxygens in the tether and was inactive in both assays. These results are consistent with the premise that NAD synthetase inhibition is responsible for the antibacterial actions and support further studies on NAD synthetase as a new target for antibacterial agents.Keywords
This publication has 16 references indexed in Scilit:
- Vaccines, biological warfare, and bioterrorismPrimary Care: Clinics in Office Practice, 2001
- Molecular mechanisms that confer antibacterial drug resistanceNature, 2000
- Role and regulation of cyclooxygenase-2 during inflammationThe American Journal of Medicine, 1999
- Socioeconomic and Behavioral Factors Leading to Acquired Bacterial Resistance to Antibiotics in Developing CountriesEmerging Infectious Diseases, 1999
- Microbial natural products: Alive and well in 1998Nature Biotechnology, 1998
- 30 years of penicillin-resistant S pneumoniae: myth or reality?The Lancet, 1997
- Resistance to Antibiotics Mediated by Target AlterationsScience, 1994
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994
- Treatment and Diagnosis of Infections Caused by Drug-Resistant Streptococcus pneumoniaeClinical Infectious Diseases, 1992
- Pneumococcal resistance to antibioticsClinical Microbiology Reviews, 1990